Roche remains the most sustainable healthcare company in the Dow Jones Sustainability Indices

By Catherine Sturman
For the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability I...

For the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI).

The largest biotech company in the world, 30 medicines developed by the company are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.

Based on an in-depth analysis of economic, social and environmental performance, the company serves as a benchmark for investors who integrate sustainability considerations into their portfolios.

 “Our most important contribution to society is the development of medicines and diagnostics that significantly improve people's lives. Open and constructive dialogue with other companies, universities, doctors and patients plays an essential role here in understanding the needs of our partners in the healthcare sector and enabling us to work together to develop more targeted medical solutions faster,” said Roche CEO Severin Schwan.

See also

One example is Roche’s partnership with the Michael J. Fox Foundation for Parkinson's Research (MJFF). Since 2010, Roche has been actively supporting the Parkinson's Progression Marker Initiative (PPMI) as part of a collaboration between companies, non-profit organisations and private individuals.

Through this partnership, Roche will soon start to offer study participants access to its digital biomarker platform, which monitors symptoms of disease progression. The anonymised data collected by the technology will be published by the PPMI publicly on a regular basis, for the whole research community – including Roche’s competitors - to access.

The hope is that this will enable the business to better investigate disease progression, speed up clinical development and improve the treatment of Parkinson's disease by accelerating clinical studies and get urgently needed treatments to patients faster.

Roche follows a holistic approach when managing sustainability: In addition to improving access to products, the company’s strategy also focuses on achieving continuous progress in areas such as social responsibility, environmental protection, supply chain sustainability, people attraction and retention.

Share

Featured Articles

Philips Future Health Index Report: AI to Cut Waiting Times

Healthcare technology leader Philips says virtual care and AI is turning in an effort to cope with demand in its Future Health Index Report 2024

HCLTech and Olympus Advance AI into the Healthcare Industry

Giants HCLTech and Olympus Corporation, have developed their partnership to utilise technology and AI to transform the healthcare industry.

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Health Insurance & Finance

McKinsey: National E-health Initiatives on the Rise

Technology & AI

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma